| Mr Jay Howard Seymour, CRNA | |
|
600 N Lewis St, New Iberia, LA 70563-2043 | |
| (337) 365-3168 | |
| (337) 369-3536 |
| Full Name | Mr Jay Howard Seymour |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 17 Years |
| Location | 600 N Lewis St, New Iberia, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033318381 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | AP05215 (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Abbeville General Hospital | Abbeville, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Abbeville General Hospital | 5395641955 | 6 |
News Archive
While it's widely held that tumors can produce blood vessels to support their growth, scientists now have evidence that cells key to blood vessel formation can also produce tumors and enable their spread.
Endo Pharmaceuticals announced today the commencement of a cash tender offer by its wholly-owned subsidiary, Endo Pharmaceuticals Solutions Inc., for any and all outstanding Ledgemont PhaRMA(SM) Secured 16% Notes due 2024 (the "Notes") of Ledgemont Royalty Sub LLC, Endo Pharmaceuticals Solutions Inc.'s wholly-owned subsidiary. The purpose of the tender offer is to acquire any and all Notes to reduce the consolidated interest expense of Endo.
A normal but concerning consequence of pregnancy is the fact that pregnant women are more susceptible to infection. University of Minnesota Medical School researchers have identified the underlying mechanisms for this physiologic immune suppression that may lead to new therapies to help ward off infections during pregnancy.
Exact Sciences Corp. today announced that it has submitted to the U.S. Food and Drug Administration the final module of the premarket approval application for Cologuard, the company's stool DNA (sDNA) colorectal cancer screening test.
› Verified 5 days ago
| Entity Name | Abbeville General Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780616094 PECOS PAC ID: 5395641955 Enrollment ID: O20031212000345 |
News Archive
While it's widely held that tumors can produce blood vessels to support their growth, scientists now have evidence that cells key to blood vessel formation can also produce tumors and enable their spread.
Endo Pharmaceuticals announced today the commencement of a cash tender offer by its wholly-owned subsidiary, Endo Pharmaceuticals Solutions Inc., for any and all outstanding Ledgemont PhaRMA(SM) Secured 16% Notes due 2024 (the "Notes") of Ledgemont Royalty Sub LLC, Endo Pharmaceuticals Solutions Inc.'s wholly-owned subsidiary. The purpose of the tender offer is to acquire any and all Notes to reduce the consolidated interest expense of Endo.
A normal but concerning consequence of pregnancy is the fact that pregnant women are more susceptible to infection. University of Minnesota Medical School researchers have identified the underlying mechanisms for this physiologic immune suppression that may lead to new therapies to help ward off infections during pregnancy.
Exact Sciences Corp. today announced that it has submitted to the U.S. Food and Drug Administration the final module of the premarket approval application for Cologuard, the company's stool DNA (sDNA) colorectal cancer screening test.
› Verified 5 days ago
| Entity Name | Eunice Anesthesiology Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386681278 PECOS PAC ID: 2365430758 Enrollment ID: O20040504001163 |
News Archive
While it's widely held that tumors can produce blood vessels to support their growth, scientists now have evidence that cells key to blood vessel formation can also produce tumors and enable their spread.
Endo Pharmaceuticals announced today the commencement of a cash tender offer by its wholly-owned subsidiary, Endo Pharmaceuticals Solutions Inc., for any and all outstanding Ledgemont PhaRMA(SM) Secured 16% Notes due 2024 (the "Notes") of Ledgemont Royalty Sub LLC, Endo Pharmaceuticals Solutions Inc.'s wholly-owned subsidiary. The purpose of the tender offer is to acquire any and all Notes to reduce the consolidated interest expense of Endo.
A normal but concerning consequence of pregnancy is the fact that pregnant women are more susceptible to infection. University of Minnesota Medical School researchers have identified the underlying mechanisms for this physiologic immune suppression that may lead to new therapies to help ward off infections during pregnancy.
Exact Sciences Corp. today announced that it has submitted to the U.S. Food and Drug Administration the final module of the premarket approval application for Cologuard, the company's stool DNA (sDNA) colorectal cancer screening test.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Jay Howard Seymour, CRNA Po Box 53533, Lafayette, LA 70505-3533 Ph: (337) 406-1044 | Mr Jay Howard Seymour, CRNA 600 N Lewis St, New Iberia, LA 70563-2043 Ph: (337) 365-3168 |
News Archive
While it's widely held that tumors can produce blood vessels to support their growth, scientists now have evidence that cells key to blood vessel formation can also produce tumors and enable their spread.
Endo Pharmaceuticals announced today the commencement of a cash tender offer by its wholly-owned subsidiary, Endo Pharmaceuticals Solutions Inc., for any and all outstanding Ledgemont PhaRMA(SM) Secured 16% Notes due 2024 (the "Notes") of Ledgemont Royalty Sub LLC, Endo Pharmaceuticals Solutions Inc.'s wholly-owned subsidiary. The purpose of the tender offer is to acquire any and all Notes to reduce the consolidated interest expense of Endo.
A normal but concerning consequence of pregnancy is the fact that pregnant women are more susceptible to infection. University of Minnesota Medical School researchers have identified the underlying mechanisms for this physiologic immune suppression that may lead to new therapies to help ward off infections during pregnancy.
Exact Sciences Corp. today announced that it has submitted to the U.S. Food and Drug Administration the final module of the premarket approval application for Cologuard, the company's stool DNA (sDNA) colorectal cancer screening test.
› Verified 5 days ago
Karly C Haik, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 301 Lucerne Dr, 3m Anesthesia, Llc, New Iberia, LA 70563 Phone: 337-374-7632 | |
Christa Hardy Swiger, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1100 Andre St, Suite 300, New Iberia, LA 70563 Phone: 337-364-9225 Fax: 337-364-6094 | |
Charlie Joseph Begnaud, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 2315 E Main St, New Iberia, LA 70560 Phone: 337-374-7104 Fax: 337-374-7641 | |
James D Dauzart Jr., CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1100 Andre St Ste 300, New Iberia, LA 70563 Phone: 225-229-3407 Fax: 337-330-2245 | |
Jean M Karpan, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1100 Andre St Ste 300, New Iberia, LA 70563 Phone: 337-364-9225 Fax: 337-364-6094 | |
Justin P Arnold, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 600 N Lewis St, New Iberia, LA 70563 Phone: 337-374-4144 |